Apr 29, 2026 07:07AM
Apr 29, 2026 06:03AM
Apr 29, 2026 04:28AM
Apr 28, 2026 07:10AM
Feb 25, 2026 05:05AM
Feb 24, 2026 08:06AM
Feb 19, 2026 05:45AM Wells Fargo Starts AxoGen, Inc. (AXGN) at Overweight
Jan 21, 2026 04:03PM
Jan 13, 2026 06:34AM
Jan 12, 2026 07:08AM
Dec 12, 2025 06:21AM
Dec 8, 2025 06:46AM
Dec 5, 2025 06:28AM
Dec 4, 2025 10:02AM AxoGen, Inc. (AXGN) PT Raised to $36 at Raymond James
Dec 4, 2025 09:19AM
Dec 4, 2025 07:27AM
Dec 4, 2025 04:08AM
Dec 1, 2025 05:12AM
Oct 30, 2025 05:37AM
Oct 30, 2025 04:17AM
Oct 29, 2025 01:26PM AxoGen, Inc. (AXGN) PT Raised to $27 at Canaccord Genuity
Oct 29, 2025 07:28AM
Oct 2, 2025 06:28AM
Oct 1, 2025 01:20PM
Sep 30, 2025 06:07AM
Aug 25, 2025 11:12AM
Aug 25, 2025 11:01AM
Aug 25, 2025 06:40AM Axogen receives three-month FDA review extension for Avance Nerve Graft
Aug 11, 2025 07:05AM
Aug 5, 2025 04:19PM
Aug 5, 2025 12:39PM
Aug 5, 2025 07:15AM
Jul 29, 2025 01:02PM
Jul 22, 2025 02:56PM
Jun 2, 2025 06:44AM AxoGen, Inc. (AXGN) PT Lowered to $23 at Cantor Fitzgerald
May 12, 2025 04:10PM
May 8, 2025 07:20AM
May 8, 2025 07:00AM
Mar 17, 2025 09:26AM
Mar 17, 2025 07:38AM
Mar 10, 2025 07:11AM
Mar 5, 2025 08:36AM Cantor Fitzgerald Reiterates Overweight Rating on AxoGen, Inc. (AXGN)
Mar 5, 2025 05:21AM
Feb 26, 2025 05:05AM
Feb 25, 2025 04:39PM
Feb 25, 2025 04:00PM
Feb 25, 2025 01:07PM
Feb 25, 2025 10:41AM
Feb 25, 2025 07:16AM AxoGen (AXGN) Tops Q4 EPS by 4c
Feb 3, 2025 08:08AM

404,872 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All